Stock Analyst Upgrades View the latest stock upgrades, analyst upgrades, and updated analyst ratings in this real-time list of recent stock analyst recommendations. This page tracks every newly published upgrade, including changes to stock ratings, analyst recommendations, and price targets, helping you quickly review all the most recent upgrades and shifts in analyst coverage. All RatingsU.S.U.K.CanadianUpgradesDowngradesInitiationsPrice Target ChangesMore Country All Countries USA (NYSE & NASDAQ)USA (All Exchanges)CanadaUnited Kingdom Sector All Sectors AerospaceAuto/Tires/TrucksBasic MaterialsBusiness ServicesCommunication ServicesComputer and TechnologyConstructionConsumer CyclicalConsumer DefensiveConsumer DiscretionaryConsumer GoodsConsumer StaplesEnergyFinanceFinancial ServicesIndustrialsManufacturingMedicalMiscellaneousMulti-Sector ConglomeratesReal EstateRetail/WholesaleServicesTransportationUtilities Market Cap All MarketCaps Mega Cap (More Than $200B)Large Cap ($10B-$200B)Mid Cap ($2B-$10B)Small Cap ($300M-$2B)Micro Cap ($50M-$300M)Nano Cap (Under $50M) Date out of range.Reporting Date All Ratings Strong Buy Buy Hold Sell Rating By Symbol By Time Added Sort Order Export CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsBNTGYBrenntagUpgraded by Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating $13.71-1.2%HoldCHRWC.H. Robinson WorldwideUpgraded by Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingStephanie MooreSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$180.64+4.4%$195.00 ➝ $200.00Hold ➝ BuyCNCCenteneUpgraded by Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingGeorge HillSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$58.28-1.5%$53.00 ➝ $80.00Hold ➝ BuyCRCCalifornia ResourcesUpgraded by CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingScott GruberSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$61.89-0.9%$74.00 ➝ $78.00Neutral ➝ BuyELVElevance HealthUpgraded by Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingGeorge HillSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$396.18-1.5%$363.00 ➝ $498.00Hold ➝ BuyFNVFranco-NevadaUpgraded by TDSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating $225.28+1.1%$292.00 ➝ $291.00Hold ➝ BuyFNVFranco-NevadaUpgraded by TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDerick MaSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$225.28+1.1%$292.00 ➝ $291.00Hold ➝ BuyFNVFranco-NevadaUpgraded by TD SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating $225.28+1.1%$291.00Hold ➝ BuyGILDGilead SciencesUpgraded by Maxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingMichael OkunewitchSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$130.69+0.1%$165.00Hold ➝ BuyHUMHumanaUpgraded by Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingGeorge HillSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$304.64-1.9%$235.00 ➝ $441.00Hold ➝ BuyYour book attached (Ad)Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.Download the Safe Trade Options Formula book for free before access closesHUMHumanaUpgraded by Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating $304.64-1.9%BuyHUMHumanaUpgraded by OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating $304.64-1.9%OutperformOKTAOktaUpgraded by CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating $89.04+3.9%Negative ➝ PositiveORLAOrla MiningUpgraded by TD SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating $12.31+1.2%Hold ➝ BuyORLAOrla MiningUpgraded by TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating $12.31+1.2%Hold ➝ BuyOVVOvintivUpgraded by ScotiabankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingKevin FiskSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$59.66-2.0%Outperform ➝ BuyPKGPackaging Corporation of AmericaUpgraded by UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAnojja ShahSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$212.99+4.8%$232.00 ➝ $248.00Neutral ➝ BuyRBRKRubrikUpgraded by OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingParam SinghSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$66.42+3.3%$85.00Market Perform ➝ OutperformSMSM EnergyUpgraded by Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJohn FreemanSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$34.77+1.3%$55.00Underperform ➝ OutperformXPOFXponential FitnessUpgraded by Northland SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating $5.39+11.6%$8.00Market Perform ➝ OutperformZGNErmenegildo ZegnaUpgraded by TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingOliver ChenSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$13.39+6.9%$13.00 ➝ $15.00Hold ➝ BuyAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 07:28 PM ET. Frequently Asked Questions What are analyst ratings? Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives. Should you trust analyst ratings? Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell." What does an analyst rating tell you about a stock? Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere. Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James FinancialBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
